1CME Stock Financial Analysis - CME Group Inc. (BIT) Stock

Overview

CME Group Inc., based in the United States, operates as a global leader in the derivatives marketplace, offering a wide array of financial instruments, including futures and options. Primarily functioning in the financial industry, CME Group provides platforms for trading of commodities, equities, foreign exchange, interest rates, and other derivatives. Key projects of the company typically focus on expanding its products and technological innovations to enhance trading efficiency and security. For instance, they frequently update their trading infrastructure and have expanded their offerings to include digital asset futures, aimed at integrating blockchain technologies within traditional financial markets. These initiatives aim to maintain CME Group's status as a crucial facilitator of capital flow in global financial markets.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for CME Group Inc. as of June 30, 2025 is 6,432.70 MM.
The operating income for CME Group Inc. as of June 30, 2025 is 4,213.80 MM.
The net income for CME Group Inc. as of June 30, 2025 is 3,768.70 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	6,432.70	4,213.80	3,768.70
2025-03-31	6,274.10	4,085.10	3,626.80
2024-12-31	6,120.30	3,936.70	3,525.80
2024-09-30	6,034.40	3,870.20	3,465.80
2024-06-30	5,787.80	3,666.20	3,303.20
2024-03-31	5,615.50	3,504.20	3,197.60
2023-12-31	5,569.10	3,458.30	3,226.20
2023-09-30	5,337.70	3,227.60	3,049.50
2023-06-30	5,227.50	3,146.20	2,978.90
2023-03-31	5,104.10	3,057.30	2,863.80
2022-12-31	5,019.40	3,002.70	2,691.00
2022-09-30	4,832.90	2,823.50	2,678.30
2022-06-30	4,714.90	2,698.40	2,925.20
2022-03-31	4,657.30	2,623.40	2,773.00
2021-12-31	4,689.70	2,604.50	2,636.40
2021-09-30	4,630.00	2,564.50	2,435.20
2021-06-30	4,600.20	2,475.20	1,920.40
2021-03-31	4,602.60	2,438.60	1,913.40
2020-12-31	4,883.60	2,673.40	2,105.20
2020-09-30	4,910.50	2,763.70	2,150.70

Income Statement: EPS

The earnings per share basic for CME Group Inc. as of June 30, 2025 is 10.35.
The earnings per share diluted for CME Group Inc. as of June 30, 2025 is 10.33.

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30	10.35	10.33
2025-03-31	9.96	9.94
2024-12-31	9.69	9.67
2024-09-30	9.52	9.51
2024-06-30	9.08	9.07
2024-03-31	8.79	8.78
2023-12-31	8.87	8.86
2023-09-30	8.39	8.38
2023-06-30	8.20	8.18
2023-03-31	7.88	7.88
2022-12-31	7.41	7.40
2022-09-30	7.34	7.33
2022-06-30	8.06	8.05
2022-03-31	7.66	7.64
2021-12-31	7.30	7.29
2021-09-30	6.80	6.78
2021-06-30	5.36	5.35
2021-03-31	5.35	5.33
2020-12-31	5.88	5.87
2020-09-30	6.01	6.00

Cash Flow: Operations, Investing, Financing

The cash from operating activities for CME Group Inc. as of June 30, 2025 is 4,196.00 MM.
The cash from investing activities for CME Group Inc. as of June 30, 2025 is -88.80 MM.
The cash from financing activities for CME Group Inc. as of June 30, 2025 is 52,573.50 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30	4,196.00	-88.80	52,573.50
2025-03-31	3,914.40	-75.80	22,351.50
2024-12-31	3,690.50	-82.60	5,076.50
2024-09-30	3,716.90	-77.70	8,649.10
2024-06-30	3,570.60	-67.70	-31,164.70
2024-03-31	3,444.10	15.30	-37,204.40
2023-12-31	3,453.80	20.90	-48,339.30
2023-09-30	3,391.00	15.60	-56,019.00
2023-06-30	3,192.10	11.50	-28,391.60
2023-03-31	3,159.30	-484.10	-42,801.80
2022-12-31	3,056.00	-489.80	-25,381.70
2022-09-30	2,742.80	-396.50	-10,895.20
2022-06-30	2,716.60	-314.10	-4,506.10
2022-03-31	2,598.80	69.50	42,731.30
2021-12-31	2,402.40	58.40	69,908.70
2021-09-30	2,394.40	-61.30	109,911.20
2021-06-30	2,074.20	-164.00	102,020.80
2021-03-31	2,561.20	-166.50	84,059.50
2020-12-31	2,715.60	-175.50	47,246.60
2020-09-30	2,775.00	-139.30	-2,514.50

Valuation Metrics : PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30

Management Effectiveness

The roa for CME Group Inc. as of June 30, 2025 is 0.03.
The roe for CME Group Inc. as of June 30, 2025 is 0.14.
The roic for CME Group Inc. as of June 30, 2025 is 0.11.
The croic for CME Group Inc. as of June 30, 2025 is 0.81.
The ocroic for CME Group Inc. as of June 30, 2025 is 0.12.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2025-06-30	0.03	0.14	0.11	0.81	0.12
2025-03-31	0.03	0.13	0.11	0.81	0.12
2024-12-31	0.03	0.12	0.11	0.37	0.11
2024-09-30	0.03	0.12	0.11	0.37	0.11
2024-06-30	0.02	0.12	0.10	-1.09	0.11
2024-03-31	0.02	0.12	0.11	-1.47	0.11
2023-12-31	0.02	0.11	0.10	-1.64	0.11
2023-09-30	0.02	0.11	0.09	-0.79	0.10
2023-06-30	0.02	0.11	0.09	-0.79	0.10
2023-03-31	0.01	0.10	0.09	-1.28	0.10
2022-12-31	0.01	0.10	0.08	-0.27	0.09
2022-09-30	0.01	0.10	0.08	-0.27	0.09
2022-06-30	0.02	0.11	0.09	-0.06	0.08
2022-03-31	0.02	0.10	0.09	1.40	0.08
2021-12-31	0.02	0.10	0.08	2.30	0.08
2021-09-30	0.02	0.09	0.08	0.00	0.08
2021-06-30	0.02	0.07	0.06	-0.01	0.07
2021-03-31	0.01	0.07	0.06	1.63	0.08
2020-12-31	0.03	0.08	0.07	1.64	0.09
2020-09-30	0.03	0.08	0.07	0.00	0.09

Gross Margins

The gross margin for CME Group Inc. as of June 30, 2025 is 1.00.
The net margin for CME Group Inc. as of June 30, 2025 is 0.58.
The operating margin for CME Group Inc. as of June 30, 2025 is 0.65.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2025-06-30	1.00	0.58	0.65
2025-03-31	1.00	0.58	0.65
2024-12-31	1.00	0.57	0.64
2024-09-30	1.00	0.57	0.64
2024-06-30	1.00	0.57	0.62
2024-03-31	1.00	0.58	0.62
2023-12-31	1.00	0.57	0.60
2023-09-30	1.00	0.57	0.60
2023-06-30	1.00	0.57	0.60
2023-03-31	1.00	0.56	0.60
2022-12-31	1.00	0.54	0.59
2022-09-30	1.00	0.54	0.59
2022-06-30	1.00	0.61	0.58
2022-03-31	1.00	0.58	0.57
2021-12-31	1.00	0.56	0.56
2021-09-30	1.00	0.53	0.55
2021-06-30	1.00	0.42	0.54
2021-03-31	1.00	0.42	0.53
2020-12-31	1.00	0.43	0.54
2020-09-30	1.00	0.44	0.56

MX:CME
BG:MX4A
US:CME	$261.94
GB:0HR2	$261.31
AT:CMEG
DE:MX4A	€228.80